Follow
Kasmintan Schrader
Kasmintan Schrader
BC Cancer, UBC
Verified email at bccancer.bc.ca
Title
Cited by
Cited by
Year
Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond
S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ...
JAMA oncology 1 (1), 23-32, 2015
7662015
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
S Shah, KA Schrader, E Waanders, AE Timms, J Vijai, C Miething, ...
Nature genetics 45 (10), 1226-1231, 2013
3612013
Germline variants in targeted tumor sequencing using matched normal DNA
KA Schrader, DT Cheng, V Joseph, M Prasad, M Walsh, A Zehir, A Ni, ...
JAMA oncology 2 (1), 104-111, 2016
3412016
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome
DL Worthley, KD Phillips, N Wayte, KA Schrader, S Healey, P Kaurah, ...
Gut 61 (5), 774-779, 2012
3082012
Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant
J Li, SL Woods, S Healey, J Beesley, X Chen, JS Lee, H Sivakumaran, ...
The American Journal of Human Genetics 98 (5), 830-842, 2016
2412016
Homologous recombination deficiency and platinum-based therapy outcomes in advanced breast cancer
EY Zhao, Y Shen, E Pleasance, K Kasaian, S Leelakumari, M Jones, ...
Clinical Cancer Research 23 (24), 7521-7530, 2017
1842017
Cancer genomics and inherited risk
ZK Stadler, KA Schrader, J Vijai, ME Robson, K Offit
Journal of clinical oncology 32 (7), 687-698, 2014
1772014
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia
S Topka, J Vijai, MF Walsh, L Jacobs, A Maria, D Villano, P Gaddam, ...
PLoS genetics 11 (6), e1005262, 2015
1752015
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants
K Lee, K Krempely, ME Roberts, MJ Anderson, F Carneiro, E Chao, ...
Human mutation 39 (11), 1553-1568, 2018
1662018
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy
KA Schrader, J Hurlburt, SE Kalloger, S Hansford, S Young, ...
Obstetrics & Gynecology 120 (2 Part 1), 235-240, 2012
1662012
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
TP Slavin, KN Maxwell, J Lilyquist, J Vijai, SL Neuhausen, SN Hart, ...
NPJ breast cancer 3 (1), 22, 2017
1572017
Hereditary diffuse gastric cancer: association with lobular breast cancer
KA Schrader, S Masciari, N Boyd, S Wiyrick, P Kaurah, J Senz, W Burke, ...
Familial cancer 7, 73-82, 2008
1552008
A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, RTEL1, Underlies Severe Immunodeficiency and Features of Hoyeraal …
BJ Ballew, V Joseph, S De, G Sarek, JB Vannier, T Stracker, KA Schrader, ...
PLoS genetics 9 (8), e1003695, 2013
1462013
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
E Pleasance, E Titmuss, L Williamson, H Kwan, L Culibrk, EY Zhao, ...
Nature Cancer 1 (4), 452-468, 2020
1382020
Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer-associated genes in families affected by breast cancer
KN Maxwell, SN Hart, J Vijai, KA Schrader, TP Slavin, T Thomas, ...
The American Journal of Human Genetics 98 (5), 801-817, 2016
1312016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
J Laskin, S Jones, S Aparicio, S Chia, C Ch'ng, R Deyell, P Eirew, A Fok, ...
Molecular Case Studies 1 (1), a000570, 2015
1312015
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
KA Schrader, S Masciari, N Boyd, C Salamanca, J Senz, DN Saunders, ...
Journal of medical genetics 48 (1), 64-68, 2011
1122011
The specificity of the FOXL2 c. 402C> G somatic mutation: a survey of solid tumors
KA Schrader, B Gorbatcheva, J Senz, A Heravi-Moussavi, N Melnyk, ...
PloS one 4 (11), e7988, 2009
1002009
Homologous recombination deficiency in breast cancer: a clinical review
WD den Brok, KA Schrader, S Sun, AV Tinker, EY Zhao, S Aparicio, ...
JCO Precision Oncology 1, 1-13, 2017
872017
Whole-genome and transcriptome analysis enhances precision cancer treatment options
E Pleasance, A Bohm, LM Williamson, JMT Nelson, Y Shen, M Bonakdar, ...
Annals of Oncology 33 (9), 939-949, 2022
822022
The system can't perform the operation now. Try again later.
Articles 1–20